FERHANOĞLU, A. B. Et Al. 2019. Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey. 6th Aegean Hematology Oncology Symposium .

FERHANOĞLU, A. B., BEKÖZ, H. S., ÖZBALAK, M. M., KARADURMUŞ, N., PAYDAŞ, S., TÜRKER, F. A., ... TOPTAŞ, T.(2019). Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey . 6th Aegean Hematology Oncology Symposium

FERHANOĞLU, AHMET Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey," 6th Aegean Hematology Oncology Symposium, 2019

FERHANOĞLU, AHMET B. Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey." 6th Aegean Hematology Oncology Symposium , 2019

FERHANOĞLU, A. B. Et Al. (2019) . "Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey." 6th Aegean Hematology Oncology Symposium .

@conferencepaper{conferencepaper, author={AHMET BURHAN FERHANOĞLU Et Al. }, title={Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey}, congress name={6th Aegean Hematology Oncology Symposium}, city={}, country={}, year={2019}}